Superior Safety of Reboxetine Over Amitryptiline in the Elderly

M. W. Agelink, H. Ullrich, P. Passenberg, K. Sayar, N. H. Brockmeyer

Superior Safety of Reboxetine Over Amitryptiline in the Elderly
Akademik YayınlarProf.Dr. Kemal Sayar

Superior Safety of Reboxetine Over Amitryptiline in the Elderly

Under antidepressive treatment with amitryptiline (100 mg/d) a 71-year old woman developed delirious symptoms, hyponatremia and a grand mal seizure followed by cardiovascular arrest. A few month later she ingested 48 mg reboxetine with suicidal intent.

You can download the whole document by clicking the ZIP image...

 

Dosyayı İndir
Bu yazıyı paylaş:
Prof.Dr. Kemal SAYAR | Superior Safety of Reboxetine Over Amitryptiline in the Elderly